In the last 12 months, insiders at Abpro Holdings, Inc. ($ABPO) filed 39 transactions with the SEC: 5 open-market purchases totaling $36,576 and 0 sales totaling $0. Net insider sentiment: net buying.
Abpro Holdings, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Suk Jin Wook (Miles) (CEO and Chairman) — 6 transactions totaling $36,576
- Lord Joanna (Director) — 2 transactions totaling $0
- Kahlon Iqbaljit (Director) — 2 transactions totaling $0
- Kahlon Iqbaljit (Not found) — 1 transaction totaling $0
- Ahmad Shahraab (Chairman and CEO) — 4 transactions totaling $0
View all SEC Filings for Abpro Holdings, Inc. (ABPO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| July 25, 2025 | Lee Soo Young | Director | A | Stock option (right to buy) | 60600 | $0.00 | 60,600.0000 | 57,517,379 | 9999.99% | 0.11% |
| July 31, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | P | Common Stock, par value $0.0001 per share | 72035 | $0.28 | 718,512.0000 | 57,517,379 | 11.14% | 0.13% |
| July 25, 2025 | Eisenberg Anthony D. | Director | A | Stock option (right to buy) | 60600 | $0.00 | 60,600.0000 | 57,517,379 | 9999.99% | 0.11% |
| July 25, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | A | Common Stock, par value $0.0001 per share | 500000 | $0.00 | 646,477.0000 | 57,517,379 | 341.35% | 0.87% |
| May 19, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | P | Common Stock, par value $0.0001 per share | 16200 | $0.26 | 146,477.0000 | 50,922,432 | 12.44% | 0.03% |
| April 29, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | P | Common Stock, par value $0.0001 per share | 4325 | $0.25 | 130,277.0000 | 50,922,432 | 3.43% | 0.01% |
| April 23, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | P | Common Stock, par value $0.0001 per share | 7460 | $0.28 | 99,360.0000 | 50,922,432 | 8.12% | 0.01% |
| April 24, 2025 | Suk Jin Wook (Miles) | CEO and Chairman | P | Common Stock, par value $0.0001 per share | 26542 | $0.34 | 125,902.0000 | 50,922,432 | 26.71% | 0.05% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 6528200 | $0.00 | 8,652,800.0000 | 640,606 | 307.27% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 1137200 | $0.00 | 8,652,800.0000 | 640,606 | 15.13% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Common Stock, par value $0.0001 per share | 987400 | $0.00 | 8,652,800.0000 | 640,606 | 12.88% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Stock option (right to buy) | 777100 | $0.00 | 777,100.0000 | 640,606 | 9999.99% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Stock option (right to buy) | 787300 | $0.00 | 787,300.0000 | 640,606 | 9999.99% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Stock option (right to buy) | 787300 | $0.00 | 787,300.0000 | 640,606 | 9999.99% | 100.00% |
| Nov. 13, 2024 | Chan Ian | Chief Executive Officer | A | Stock option (right to buy) | 577500 | $0.00 | 577,500.0000 | 640,606 | 9999.99% | 90.15% |
| Nov. 13, 2024 | Suk Jin Wook (Miles) | Co-CEO & Chairman | A | Stock option (right to buy) | 613500 | $0.00 | 613,500.0000 | 640,606 | 9999.99% | 95.77% |
| Nov. 13, 2024 | Suk Jin Wook (Miles) | Co-CEO & Chairman | A | Common Stock, par value $0.0001 per share | 91900 | $0.00 | 91,900.0000 | 640,606 | 9999.99% | 14.35% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 24300 | $0.00 | 24,300.0000 | 640,606 | 9999.99% | 3.79% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 538600 | $0.00 | 538,600.0000 | 640,606 | 9999.99% | 84.08% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 29800 | $0.00 | 29,800.0000 | 640,606 | 9999.99% | 4.65% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 40800 | $0.00 | 40,800.0000 | 640,606 | 9999.99% | 6.37% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 41700 | $0.00 | 41,700.0000 | 640,606 | 9999.99% | 6.51% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 74600 | $0.00 | 74,600.0000 | 640,606 | 9999.99% | 11.65% |
| Nov. 13, 2024 | Markelewicz Robert J. Jr. | Chief Medical Officer | A | Stock option (right to buy) | 10200 | $0.00 | 10,200.0000 | 640,606 | 9999.99% | 1.59% |
| Nov. 7, 2023 | Ahmad Shahraab | Chairman and CEO | J | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 7,199,999.0000 | 0 | 0.69% | 0.00% |
| Nov. 6, 2023 | Ahmad Shahraab | Chairman and CEO | J | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 7,249,999.0000 | 0 | 0.69% | 0.00% |
| Nov. 6, 2023 | Kahlon Iqbaljit | Not found | J | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Kahlon Iqbaljit | Director | M | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Kahlon Iqbaljit | Director | M | Series B Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Ahmad Shahraab | Chairman and CEO | M | Series A Common Stock, par value $0.0001 per share | 7199999 | $0.00 | 7,199,999.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Ahmad Shahraab | Chairman and CEO | M | Series B Common Stock, par value $0.0001 per share | 7199999 | $0.00 | 1.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Schiano Dominick | Director | M | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Schiano Dominick | Director | M | Series B Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Stanwood Darren | Director | M | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Stanwood Darren | Director | M | Series B Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Dove Bryan | Director | M | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Dove Bryan | Director | M | Series B Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 18, 2023 | Lord Joanna | Director | M | Series A Common Stock, par value $0.0001 per share | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Lord Joanna | Director | M | Series B Common Stock, par value $0.0001 per share | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |